Abstract
Background: Indian-Asian multiple sclerosis behaves somewhat differently from Western disease. It is not known if the response to β-interferon is also different.
Aim: To demonstrate the decrease in relapses with β-interferon in Indian patients with multiple sclerosis.
Patients and Methods: Patients with relapsing-remitting or secondary progressive multiple sclerosis with at least two relapses were started on β-interferon. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1763